Therapy News and Research

RSS

ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

D3 Radiation Services announced today that the American Board of Radiology (ABR) has qualified eDataAudit--a new service designed to reduce errors in the delivery of radiation therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of Certification (MOC).

15 Jul 2010

Aeterna Zentaris' partner Keryx receives FDA orphan-drug designation for perifosine in neuroblastoma

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc., has been granted orphan-drug designation by the U.S. Food and Drug Administration for perifosine, Aeterna Zentaris' novel, potentially first-in-class, oral Akt inhibitor, for the treatment of neuroblastoma.

15 Jul 2010

Amorfix grants Biogen Idec exclusive worldwide rights to lead ALS monoclonal antibodies

Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.

15 Jul 2010

Aboriginals smoke less cigarettes per day than others: Study

A new study showed that Aboriginal smokers residing in remote communities have a significantly lower consumption of cigarettes than the rest of the population. The study was published in the Australian and New Zealand Journal of Public Health on Wednesday.

14 Jul 2010

Hendra virus treatment to be ready in a few months

Of the dozen people who were exposed to a horse infected with the Hendra virus, 11 have been cleared of the infection by repeated tests on Queensland's Sunshine Coast. These 12 people had first come into contact with the infected horse at Tewantin in May and have since then been subjected to testing to rule out infection with the deadly virus. It is expected that the 12th person will also be cleared soon. Quarantine restrictions were also lifted last month.

14 Jul 2010

SANUWAVE Health introduces orthoPACE device in Europe

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports the European launch of the orthoPACE device intended for use in orthopedic, trauma and sports medicine indications following CE mark approval last month.

14 Jul 2010

Collagen Induction Therapy and Ultrasonic Microdermabrasion demonstrations at Lecada's open house

An open house on Thursday, June 17th, celebrated Lecada Medical Artistry's grand opening at 3710 West Azeele Street, Tampa. Lecada offers innovative treatments for face and body that provide aesthetic and anti-aging solutions designed to help you look and feel your best.

14 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

Study finds substantial regional variation in treatment practices for older adults with ESRD

There is substantial regional variation in treatment practices for care of older adults with end-stage renal disease, including receipt of hospice care and discontinuation of dialysis before death, according to a study in the July 14 issue of JAMA.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

New prediction tool estimates risk for recurrence after breast-conserving surgery in DCIS patients

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.

14 Jul 2010

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

New research studies presented at Alzheimer's Association International Conference

The primary therapeutic target in Alzheimer's disease has been the beta amyloid peptide, which clusters outside cells in the brain to form sticky clumps known as plaques. Recently, more attention has been given to the tau protein, which aggregates inside the brain cells of people with Alzheimer's, forming neurofibrillary tangles. Precisely how these proteins interact in causing the disease is unclear.

14 Jul 2010

Study suggests protein interferon therapy for individuals with asthma

An immune-system protein already used to treat diseases like multiple sclerosis, hepatitis C and a variety of cancers might also aid asthma patients, UT Southwestern Medical Center researchers have found.

14 Jul 2010

New prediction tool may determine patients' risk for ductal carcinoma

14 Jul 2010

The Samuel Waxman Cancer Research Foundation announces research grants totaling $1.54 million

The Samuel Waxman Cancer Research Foundation (SWCRF) has awarded 13 collaborative research grants and 3 individual research grants, totaling $1.54 million. The 16 grants represent a portion of the science grant program at the Foundation, which will award more than $2 million this year to cancer research.

14 Jul 2010

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

Italian scientists pioneering a new gene transfer treatment for the blood disorder β-thalassemia have successfully completed preclinical trials, claiming they can correct the lack of beta-globin (β-globin) in patients' blood cells which causes the disease. The research, published in EMBO Molecular Medicine, reveals how gene therapy may represent a safe alternative to current cures that are limited to a minority of patients.

14 Jul 2010

HHS grants seek to encourage health care workforce diversity

The Washington Post: "It is a sign of the economic times: Nursing students at Howard University work part-time jobs and still cannot keep up with tuition. … At the start of the month, the game changed. Howard received $1.5 million from the Obama administration to train student nurses and others in sciences such as radiology and occupational therapy.

14 Jul 2010

LSUHSC Professor awarded $2.1M grant to determine role of PCP

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to determine the role and identify which T-helper cells fight the opportunistic infection, Pneumocystis carinii pneumonia, which can be a complication of HIV/AIDS.

14 Jul 2010

Astra Tech expands Atlantis patient-specific abutment options

Astra Tech expands the Atlantis patient-specific abutment options to include Dentsply Friadent's XiVE and Frialit implants and Straumann's Standard/Standard Plus (Wide Neck) implants for North American customers.

13 Jul 2010

Therapy News and Research

ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

Aeterna Zentaris' partner Keryx receives FDA orphan-drug designation for perifosine in neuroblastoma

Amorfix grants Biogen Idec exclusive worldwide rights to lead ALS monoclonal antibodies

Aboriginals smoke less cigarettes per day than others: Study

Hendra virus treatment to be ready in a few months

SANUWAVE Health introduces orthoPACE device in Europe

Collagen Induction Therapy and Ultrasonic Microdermabrasion demonstrations at Lecada's open house

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

Study finds substantial regional variation in treatment practices for older adults with ESRD

Highlights of AAPM 52nd meeting

New prediction tool estimates risk for recurrence after breast-conserving surgery in DCIS patients

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

New research studies presented at Alzheimer's Association International Conference

Study suggests protein interferon therapy for individuals with asthma

New prediction tool may determine patients' risk for ductal carcinoma

The Samuel Waxman Cancer Research Foundation announces research grants totaling $1.54 million

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

HHS grants seek to encourage health care workforce diversity

LSUHSC Professor awarded $2.1M grant to determine role of PCP

Astra Tech expands Atlantis patient-specific abutment options

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News